Abstract
PCR76 Generating Health-State Utility Values in Patients Treated with Second-Line Systemic Therapy for Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have